A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer
Clinical trial NCT04616040 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04616040
- Sponsor
- Peking University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 1030
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.